VanEck’s €7.4bn Dividend ETF Gains an Irish Sibling as Earnings Season Puts the Portfolio Under the Microscope

VanEck launches TDVX, an ex-US dividend ETF on the LSE, offering accumulating shares and tax efficiency, while flagship TDIV nears record highs with €7.4bn AUM.

The largest dividend ETF in Europe is no longer flying solo. VanEck has launched a structurally distinct companion fund, the VanEck Morningstar Developed Markets ex-US Dividend Leaders UCITS ETF (TDVX), which began trading on the London Stock Exchange on 23 April 2026. The new vehicle mirrors the methodology of the flagship TDIV but strips out US equities entirely, creating a clear division of labour for income-focused investors.

Why a Second Fund Was Necessary

The decision to launch TDVX stems from regulatory constraints that have long limited the flagship’s appeal to certain investor groups. While TDIV is domiciled in the Netherlands and can only offer distributing share classes, TDVX is registered in Ireland — a jurisdiction that permits accumulating share classes. That distinction matters for investors seeking automatic reinvestment of dividends and more favourable withholding tax treatment on international securities.

VanEck product manager Dmitrii Ponomarev confirmed that these structural limitations were the driving force behind the new fund. The result is a straightforward split: TDIV for those who want regular payouts, TDVX for those prioritising compounding and tax efficiency.

Flagship Near Record Highs

The parent fund itself is firing on all cylinders. TDIV now manages roughly €7.4bn in assets, with its net asset value trading at €52.76 — just a whisker below its 52-week high of €52.86. Year-to-date returns stand at over nine percent, and the fund has attracted $2.5bn in inflows so far in 2026.

The portfolio holds 115 positions, with Pfizer (4.67%), Roche (4.41%) and HSBC (4.27%) representing the largest individual bets. Financials dominate at sector level with a 31% weighting, followed by energy at around 20%.

Earnings Season Brings Mixed Signals

The current reporting period carries outsized significance for TDIV. Its top ten holdings account for more than 35% of assets, meaning quarterly results from these heavyweights can move the needle considerably.

Roche posted first-quarter 2026 revenue of CHF14.7bn. In constant currencies, that represented six percent growth, though the strong Swiss franc dragged reported sales down five percent. The company reaffirmed its full-year guidance for mid-single-digit revenue growth and high-single-digit core earnings per share growth, both measured in constant currencies.

Nestlé painted a weaker picture. Group revenue fell to CHF21.3bn in the first quarter, a decline of 5.7% year-on-year, weighed down by a baby formula recall. Organic growth came in at 3.5%. Management maintained its annual forecast but flagged elevated geopolitical and macroeconomic risks.

PepsiCo provided a bright spot, beating analyst expectations on both earnings per share and revenue for the first quarter. The company also announced a four percent dividend increase starting with its June payout — a clear signal to income-oriented investors.

Key Reports Still to Come

Several core holdings have yet to report. Pfizer is scheduled to release numbers on 5 May, following a late-stage trial success for Elrexfio, a multiple myeloma treatment. Novo Nordisk follows on 6 May, with Allianz also due later in the month. Verizon Communications, a top-five position with a 4.66% weighting, remains on the agenda as well. The outcome of these reports is likely to shape short-term sentiment around the fund.

June Rebalancing Looms

Alongside the earnings calendar, a structural event is approaching. The underlying Morningstar index undergoes its semi-annual rebalancing in June. To remain in the index, stocks must have paid a dividend in the past twelve months, not cut their dividend per share relative to the five-year average, and maintain a forward payout ratio below 75%. Which current holdings clear these hurdles will become clear in the weeks ahead.

Timing That Taps a Broader Trend

The launch of TDVX is no accident of timing. Global dividend funds attracted roughly $24bn in inflows during the first quarter of 2026 — the strongest opening quarter in four years. The MSCI All Country World ex-USA has outperformed the S&P 500 by double-digit percentage points over the past twelve months, as investors rotate toward tangible income streams away from US technology giants that are ploughing capital into artificial intelligence rather than shareholder payouts.

The index underlying both funds is reconstituted semi-annually in June and December. The next rebalancing falls squarely in the middle of the current earnings season — a test for TDIV and the first real proving ground for its newly listed Irish sibling.